News & Events
Lianhe Aigen CPHI Milan 2024 Exhibition Review
Oct. 11, 2024
Lianhe Aigen Pharma Co., Ltd. welcomed partners and experts of pharmaceutical industry from all over the world. Through comprehensive and multi-dimensional exchanges, Lianhe Aigen showcased one-stop CRDMO service capabilities for innovative drug solutions, as well as its Corporate brand image.
Sep. 04, 2024
Lianhe Aigen’s First Quality Month Event Grandly Launched, Starting a New Journey of Quality Improvement
Aug. 01, 2024
Lianhe Aigen Receives EcoVadis Silver Medal for Sustainability for the First Time: Embarking on a New Journey Towards Green Development
Lianhe Aigen CPHI Shanghai 2024 Exhibition Review
Jun. 22, 2024
Business and Technical teams from Lianhe Aigen participated in the exhibition, engaging in enthusiastic communication and exchange with partners, pharmaceutical industry experts, and entrepreneurs. Discussions with both new and existing clients focused on cooperation and development. The exhibition showcased Lianhe Aigen's one-stop CRDMO service ca
Lianhe Aigen passed the FDA audit inspection
May. 08, 2024
Lianhe Aigen Pharma Co., Ltd. (formerly known as Lianhe Chemical Technology (Taizhou) Co., LTD.) is located at No. 3 Donghai 8th Avenue, Toumengang New District, Linhai, Taizhou, Zhejiang, which is mainly customizes and produces pharmaceutical intermediates and API for customers.
The second-level production safety standardization review passed smoothly
May. 01, 2024
November 7~8, 2023, Zhejiang Provincial Institute of Emergency Management Science and other 5 review experts visited our company for secondary safety production standardization on-site review. Lianhe Aigen Pharma Co., Ltd. (formerly known as Lianhe Chemical Technology (Taizhou) Co., LTD.) successfully passed the secondary safety production standard
What Can We Help You?
We provide customers with one-stop CRDMO services covering the entire lifecycle of drugs.